Home / Without Label / CTMX CytomX Therapeutics, Inc. gains 16% Feb 5, 2018

Monday, February 5, 2018

CTMX CytomX Therapeutics, Inc. gains 16% Feb 5, 2018

priceSeries Monday, February 05, 2018 0 Comment

Preclinical biotech developing tumor-activated cancer immunotherapies. http://www.priceseries.com/trade/CTMX-CytomX-Therapeutics-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018010320180205.html

Posted by : priceSeries Monday, February 05, 2018

No Comments

Subscribe to: Post Comments (Atom)